MetaCap

Who Owns Theriva Biologics Stock?

NYSE: TOVXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.217-0.0101 (-4.45%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
4.32%
Institutional holders
27
  • Institutions 4.3%
  • Insiders 1.6%
  • Public and other 94.1%

Who owns Theriva Biologics stock?

Institutional investors own about 4.3% of Theriva Biologics's shares, spread across 27 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 1.63% of TOVX.

The largest institutional holders are Vanguard Capital Management LLC (1.06%), Jane Street Group, LLC (0.72%) and Geode Capital Management, LLC (0.64%). Together, the top 10 institutions control 4.0% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their TOVX positions and 4 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of TOVX

Theriva Biologics top institutional holders
InstitutionShares% HeldChange
Vanguard Capital Management LLC486.18K1.06%+152.7%
Jane Street Group, LLC331.92K0.72%+87.5%
Geode Capital Management, LLC294.02K0.64%-34.7%
Vanguard Fiduciary Trust Co241.78K0.53%0.0%
Ikarian Capital, LLC112.08K0.24%0.0%
Virtu Financial LLC87.14K0.19%-65.6%
Northern Trust Corporation82.70K0.18%+100.0%
Renaissance Technologies, LLC63.71K0.14%+100.0%
UBS Group AG61.05K0.13%-72.9%
Xtx Topco Ltd53.87K0.12%-43.1%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of TOVX

Theriva Biologics top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund486.18K1.06%
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund248.27K0.54%
Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund26.07K0.06%
Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St310.00%

Frequently asked questions

Who is the largest shareholder of Theriva Biologics?

Vanguard Capital Management LLC is the largest institutional shareholder of TOVX, owning 1.06% of shares outstanding (486.18K shares) as of its latest 13F filing.

What percentage of Theriva Biologics is owned by institutions?

Institutions own about 4.3% of TOVX shares and 4.4% of the public float.

How much of Theriva Biologics do insiders own?

Insiders, such as officers and directors, own about 1.63% of TOVX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related